Preview Mode Links will not work in preview mode

This Week in Cardiology

Jun 11, 2021

COVID vaccine myocarditis, AF post-stroke, semaglutide, and iPhones and cardiac devices are the topics John Mandrola, MD, discusses in this week’s podcast.


More Evidence Links COVID Vaccines to Rare Cases of Myocarditis in Youth

- Symptomatic Acute Myocarditis in Seven Adolescents Following the Pfizer-BioNTech COVID-19 Vaccination

- At Least 18 Cases of Apparent Heart Problems in Young People in CT After COVID-19 Vaccine

- C.D.C. Is Investigating a Heart Problem in a Few Young Vaccine Recipients

- EMA Statement:

- Is the Second Shot Giving Young Men a Dangerous Heart Condition?

- Report to FDA

AF and Stroke

Evidence Mounts for Implantable AF Monitoring After Stroke

- The STROKE-AF Randomized Clinical Trial

- The PER DIEM Randomized Clinical Trial


FDA Approves 'Game Changer' Semaglutide for Weight Loss

iPhone 12 and Cardiac Device

Evidence Builds for iPhone 12 Interference With Cardiac Devices

- Magnetic Interference on Cardiac Implantable Electronic Devices From Apple iPhone MagSafe Technology

- Letter to the Editor—Lifesaving therapy inhibition by phones containing magnets

- Smart wearable device accessories may interfere with implantable cardiac devices


Feb 26, 2021 This Week in Cardiology Podcast

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact